Though theoretical, the work points to the critical importance of what has been a poorly appreciated aspect of the interaction between a virus and those naturally produced defensive proteins called antibodies that fight infection.
By manipulating this multi-stage interactive process -- known as antibody interference -- to advantage, the scientists believe it may be possible to design more powerful vaccines than exist today.
The findings are described in the May 11 online edition of the Proceedings of the National Academy of Sciences.
"We have proposed that antibody interference plays a major role in determining the effectiveness of the antibody response to a viral infection," said Ned Wingreen, a professor of molecular biology and a member of the Lewis-Sigler Institute for Integrative Genomics. "And we believe that in order to get a more powerful vaccine, people are going to want one that minimizes this interference."
Other authors on the paper include Simon Levin, the George M. Moffett Professor of Biology, and Wilfred Ndifon, a former graduate student in Levin's lab and first author on the paper.
When a virus like influenza attacks a human, the body mounts a defense, producing antibodies custom-designed to attach themselves to the virus, blocking it from action and effectively neutralizing its harmful effects on the body.
Analyzing data about viral structure, antibody types and the reactions between them produced by virology laboratories across the country, Ndifon noticed a perplexing pattern. He found that antibodies were often better at protecting against a slightly different virus, a close cousin, than against the virus that spurred their creation. This is known as cross-reactivity.
A closer look, using techniques that combine computing and biophysics, suggested that a phenomenon known as antibody interference was at play. It arises when a virus prompts the creation of multiple types of antibodies. During a viral attack, what then transpires is that antibodies vie with each other to defend the body and sometimes crowd each other out as they attempt to attach themselves to the surface of the virus.
Strangely, antibodies that are actually less effective at protecting the body against a specific virus are often equally adept at attaching themselves to the virus, blocking the more effective antibodies from doing their job. The scientists suggest that if a way can be found to weaken the binding of the less effective antibodies, then this might constitute a new approach to vaccine design. Indeed, the perplexing pattern of enhanced cross-reactivities observed by Ndifon can be attributed to viruses that differ only at the sites on their surfaces where the less effective antibodies bind. Such variants would make ideal vaccine strains, guiding the immune system to produce two distinct types of antibodies: effective ones that are well matched to and good at binding to the infecting virus, and ineffective ones that are poorly matched to and bad at binding to the infecting virus, and consequently stay out of the way.
Today, vaccine designers, such as those working on new forms of flu vaccines, center their efforts upon developing a weakened strain of a virus that matches as closely as possible the anticipated infecting strain. Patients are then inoculated with this attenuated virus to provoke the creation of antibodies that will protect against future attacks.
The Princeton scientists suggest their findings show that a better way might involve intentionally developing a vaccine strain that differs from the anticipated infectious virus at the sites where less effective antibodies bind. In this way, the ineffective antibodies would stay out of the way in the face of a real influenza virus, allowing the effective antibodies to more fiercely fight the dangerous infecting strain when it comes along.
The team does not expect to develop a vaccine but is hoping to inspire others. Wingreen is a theoretical physicist, Levin is a theoretical ecologist and Ndifon was a graduate student learning theoretical biology. "Our best bet is to express our ideas as clearly as we can and hope someone will find them interesting and do the necessary experiments to verify or disprove them," Wingreen said.
The research was supported by a Burroughs Wellcome graduate fellowship and by the Defense Advanced Research Projects Agency.
Kitta MacPherson | EurekAlert!
Hunting pathogens at full force
22.03.2017 | Helmholtz-Zentrum für Infektionsforschung
A 155 carat diamond with 92 mm diameter
22.03.2017 | Universität Augsburg
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
22.03.2017 | Materials Sciences
22.03.2017 | Physics and Astronomy
22.03.2017 | Materials Sciences